» Authors » Ralf E Harskamp

Ralf E Harskamp

Explore the profile of Ralf E Harskamp including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 95
Citations 841
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Himmelreich J, Virdone S, Camm A, Pieper K, Harskamp R, Verheugt F, et al.
Open Heart . 2025 Jan; 12(1. PMID: 39832940
Aims: This study aimed to determine the robustness, reproducibility and representativeness of the landmark Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (AF) (ARISTOTLE) and Rivaroxaban...
2.
Hummel B, Harskamp R, Vester A, Galenkamp H, Mommersteeg P, van Valkengoed I
Int J Cardiol Cardiovasc Risk Prev . 2025 Jan; 24():200361. PMID: 39807448
Objective: While chest pain is a common symptom, its prevalence among women and men across ethnic groups is unknown. Moreover, how chest pain is associated with general practitioner (GP) and...
3.
van Apeldoorn J, Jansen L, Hoevenaar-Blom M, Harskamp R, Galenkamp H, van den Born B, et al.
High Blood Press Cardiovasc Prev . 2024 Nov; 32(1):69-77. PMID: 39488619
West African (WA) migrants in Europe have higher hypertension rates than the host populations. For African migrants, guidelines recommend diuretics and/or calcium channel blockers (CCB) for primary cardiovascular disease prevention,...
4.
van den Bulk S, Manten A, Bonten T, Harskamp R
Ann Fam Med . 2024 Sep; 22(5):426-436. PMID: 39313342
Purpose: Chest pain frequently poses a diagnostic challenge for general practitioners (GPs). Utilizing risk stratification tools might help GPs to rule out acute coronary syndrome (ACS) and make appropriate referral...
5.
van Apeldoorn J, Hageman S, Harskamp R, Agyemang C, van den Born B, van Dalen J, et al.
Int J Cardiol . 2024 Sep; 417:132525. PMID: 39244095
Background: Current prediction models for mainland Europe do not include ethnicity, despite ethnic disparities in cardiovascular disease (CVD) risk. SCORE2 performance was evaluated across the largest ethnic groups in the...
6.
Brik T, Harskamp R, Himmelreich J
Eur Heart J Suppl . 2024 Aug; 26(Suppl 4):iv12-iv18. PMID: 39099572
Atrial fibrillation (AF) is a common arrhythmia associated with an increased risk of stroke, which can be effectively reduced by prophylaxis initiation and integrated care to reduce cardiovascular risk and...
7.
Himmelreich J, Virdone S, Camm J, Pieper K, Harskamp R, Oto A, et al.
Open Heart . 2024 Jul; 11(2). PMID: 38955399
Background: The extent to which differences in results from Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) and Rivaroxaban Once Daily Oral Direct Factor Xa...
8.
Manten A, Harskamp R, Busschers W, Moll van Charante E, Himmelreich J
Fam Pract . 2024 May; 41(5):832-840. PMID: 38801727
Introduction: Telephone triage is pivotal for evaluating the urgency of patient care, and in the Netherlands, the Netherlands Triage Standard (NTS) demonstrates moderate discrimination for chest pain. To address this,...
9.
De Clercq L, Himmelreich J, Harskamp R
Diagnosis (Berl) . 2024 May; 11(4):380-388. PMID: 38741552
Objectives: Proper coding of heart failure (HF) in electronic health records (EHRs) is an important prerequisite for adequate care and research towards this vulnerable patient population. We set out to...
10.
Karregat E, de Koning M, Himmelreich J, Koetsier D, de Jong J, Moll van Charante E, et al.
Prim Health Care Res Dev . 2024 Apr; 25:e18. PMID: 38634311
Aim: To evaluate the use of a single-lead electrocardiography (1L-ECG) device and digital cardiologist consultation platform in diagnosing arrhythmias among general practitioners (GPs). Background: Handheld 1L-ECG offers a user-friendly alternative...